445
Participants
Start Date
October 14, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2026
Tenecteplase (1/3 systemic weight based dose)
50mg reconstituted to 20mL for intracoronary infusion at 1/3 weight based dose.
Sterile water for injection (WFI)
Placebo comparative arm.
NOT_YET_RECRUITING
Auckland City Hospital, Auckland
NOT_YET_RECRUITING
Prince of Wales Hospital, Randwick
RECRUITING
Royal Prince Alfred Hospital, Camperdown
NOT_YET_RECRUITING
Northern Beaches Hospital, Frenchs Forest
RECRUITING
Concord Repatriation General Hospital, Concord
RECRUITING
Liverpool Hospital, Liverpool
NOT_YET_RECRUITING
Bankstown-Lidcombe Hospital, Bankstown
RECRUITING
John Hunter Hospital, New Lambton Heights
WITHDRAWN
Wollongong Hospital, Wollongong
NOT_YET_RECRUITING
Wellington Hospital, Wellington
RECRUITING
Sunshine Hospital, Saint Albans
RECRUITING
The Northern Hospital, Epping
RECRUITING
Box Hill Hospital, Box Hill
RECRUITING
Jessie McPherson Private Hospital, Clayton
RECRUITING
Victorian Heart Hospital, Clayton
RECRUITING
Frankston Hospital, Frankston
RECRUITING
Waikato Hospital, Hamilton
NOT_YET_RECRUITING
Christchurch Hospital, Christchurch
RECRUITING
Royal Adelaide Hospital, Adelaide
RECRUITING
Lyell McEwin Hospital, Elizabeth Vale
RECRUITING
Royal Perth Hospital, Perth
NOT_YET_RECRUITING
Fiona Stanley Hospital, Murdoch
University of Sydney
OTHER